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Background: The presence of perfluoroalkyl acids (PFAAs) in breast milk has been documented, 
but their lactational transfer has been rarely studied. Determination of the elimination rates of 
these chemicals during breastfeeding is important and critical for assessing exposure in mothers 
and infants.
oBjectives: We aimed to investigate the association between breastfeeding and maternal serum 
concentrations of perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS), perfluoro­
nonanoic acid (PFNA), and perfluorohexane sulfonate (PFHxS). For a subset of the population, for 
whom we also have their infants’ measurements, we investigated associations of breastfeeding with 
infant serum PFAA concentrations.
Methods: The present analysis included 633 women from the C8 Science Panel Study who had 
a child < 3.5 years of age and who provided blood samples and reported detailed information on 
breastfeeding at the time of survey. PFAA serum concentrations were available for all mothers and 
8% (n = 49) of the infants. Maternal and infant serum concentrations were regressed on duration of 
breastfeeding.
results: Each month of breastfeeding was associated with lower maternal serum concentrations 
of PFOA (–3%; 95% CI: –5, –2%), PFOS (–3%; 95% CI: –3, –2%), PFNA (–2%; 95% CI: 
–2, –1%), and PFHxS (–1%; 95% CI: –2, 0%). The infant PFOA and PFOS serum concentrations 
were 6% (95% CI: 1, 10%) and 4% (95% CI: 1, 7%) higher per month of breastfeeding.
conclusions: Breast milk is the optimal food for infants, but is also a PFAA excretion route for 
lactating mothers and exposure route for nursing infants.
citation: Mondal D, Weldon RH, Armstrong BG, Gibson LJ, Lopez­Espinosa MJ, Shin HM, 
Fletcher T. 2014. Breastfeeding: a potential excretion route for mothers and implications for 
infant exposure to perfluoroalkyl acids. Environ Health Perspect 122:187–192; http://dx.doi.
org/10.1289/ehp.1306613
Introduction
Breast milk is the natural and optimal food 
for infants (World Health Organization 
2012). The diverse and compelling advan­
tages of breastfeeding for infants, mothers, 
families, and societies are well documented 
(Gartner et al. 2005). However, the presence 
of environmental chemicals in breast milk 
and their potential adverse effects on infant 
development and health are of concern. The 
transfer to breast milk and excretion during 
lactation, or the depuration (LaKind et al. 
2001), of some persistent lipophilic organic 
pollutants such as polychlorinated biphenyls 
(PCBs) and polybrominated diphenyl ethers 
(PBDEs) has been extensively documented 
(Dekoning and Karmaus 2000; Hites 2004).
In contrast to PCBs and PBDEs, which 
bind to lipids, perfluoroalkyl acids (PFAAs) 
strongly bind to the protein fraction in blood, 
notably to albumin (Voelkel et al. 2008). 
Thus, lactational transfer of PFAAs, including 
perfluorooctanoic acid (PFOA), perfluoro­
octane sulfonate (PFOS), perfluorononanoic 
acid (PFNA), and perfluorohexane sulfonate 
(PFHxS), is believed to be caused by bind­
ing to milk proteins (Butenhoff et al. 2006; 
Fromme et al. 2010; Kärrman et al. 2010). 
The protein concentration in human milk 
(9–11 g/L) is about 3–5 times lower than the 
protein fraction in the blood (35–50 g/L) and 
this may explain, in part, why PFAA con­
centrations are much lower in human milk 
than in maternal serum (Fromme et al. 2010; 
Kärrman et al. 2010; von Ehrenstein et al. 
2009). The concentration in breast milk as a 
proportion of the concentration in maternal 
serum ranges from 3.4% to 11% for PFOA 
(Haug et al. 2011; Kim et al. 2011; Liu et al. 
2011), 1% to 2% for PFOS (Fromme et al. 
2010; Haug et al. 2011; Kärrman et al. 2007; 
Kim et al. 2011; Liu et al. 2011), 0.7% to 
5% for PFNA (Kärrman et al. 2007; Kim 
et al. 2011; Liu et al. 2011), and 2% to 
3% for PFHxS (Kärrman et al. 2007; Kim 
et al. 2011).
Although PFAA concentrations in mater­
nal milk are relatively low, findings from sev­
eral studies (Fromme et al. 2010; Kärrman 
et al. 2007; Tao et al. 2008; Thomsen et al. 
2010) suggest that breast milk is the pri­
mary route of exposure for these contami­
nants for breastfed infants. A recent study 
estimated that breast milk contributed > 94% 
and > 83% of the total PFOS and PFOA 
exposure, respectively, in infants 6 months 
of age (Haug et al. 2011). Further, given this 
transfer of PFOA and PFOS to the infants, 
this route could be a significant excretion 
pathway for the lactating mothers. A lon­
gitudinal study measured concentrations in 
breast milk monthly in nine women and esti­
mated that during 1 year of breastfeeding, the 
concentration of PFOA and PFOS in breast 
milk fell by about 94% and 37%, respec­
tively (Thomsen et al. 2010). The correlation 
coefficient between breast milk and maternal 
serum concentrations was 0.99 for PFOA 
and 0.63 for PFOS. Strong correlations have 
also been reported by others (Fromme et al. 
2010; Haug et al. 2011; Kärrman et al. 2007; 
Nakata et al. 2009).
We previously reported on the asso­
ciations between maternal and infant serum 
levels of PFOA and PFOS in a population 
exposed to high concentrations of PFOA 
released by a chemical plant, in the Mid­
Ohio Valley, USA (Frisbee et al. 2009; 
Mondal et al. 2012). For a small subset, 35 
mother–infant pairs, our data allowed classi­
fication of mothers by the recorded “inten­
tion” to breastfeed as stated in birth records 
at the time of delivery. In infants 1–3 years 
Address correspondence to T. Fletcher, London 
School of Hygiene & Tropical Medicine, 15–17 
Tavistock Place, London WC1H 9SH, United 
Kingdom. Telephone: 44 20 7927 2429. E­mail: 
tony.fletcher@lshtm.ac.uk
We are grateful to the participants for their con­
tributions to this study, and for comments from 
V. Gallo, S. Bartell, and C. Stein.
This work was funded by the C8 Class Action 
Settlement Agreement (Circuit Court of Wood 
County, WV, USA) between DuPont and plaintiffs, 
which resulted from releases of perfluorooctanoic 
acid (PFOA, or C8) into drinking water. It is one 
of the C8 Science Panel Studies undertaken by the 
court­approved C8 Science Panel established under 
the same settlement agreement. Funds were adminis­
tered by the Garden City Group (Melville, NY) that 
reports to the Court. M.­J.L.­E. holds a grant from 
the Instituto de Salud Carlos III of Spain (Programa 
Miguel Servet: CP11/0178). 
The authors of this manuscript declare that their 
ability to design, conduct, interpret, or publish 
research was unimpeded by and fully independent of 
the court and/or settling parties. The views expressed 
are not necessarily those of the funding bodies.
The authors declare they have no actual or potential 
competing financial interests.
Received: 5 February 2013; Accepted: 25 November 
2013; Advance Publication: 26 November 2013; Final 
Publication: 1 February 2014.
Mondal et al.
188 volume 122 | number 2 | February 2014 • Environmental Health Perspectives
of age, we observed higher PFOA and PFOS 
infant:mother serum ratios for mothers clas­
sified as having intended to exclusively breast 
feed (1.83 and 1.35, respectively) compared 
to ratios for mothers with breast and bottle 
or only bottle feeding intentions (1.14 and 
1.12, respectively). This suggests that infants 
have higher serum levels, and/or that mothers 
have lower serum levels of these compounds 
as a consequence of breastfeeding. However, 
we did not have information on whether 
they carried out breastfeeding as per their 
stated intention at the time of birth, nor the 
 duration of such feeding.
A subset of mothers enrolled in the C8 
Health Project, whose infants were born 
shortly before or after the time of measuring 
PFAA serum concentrations in 2005–2006, 
were interviewed about their infant’s health 
and were asked to report information about 
initiation and duration of breastfeeding 
for the index infant. The aims of the pres­
ent study are to investigate the association of 
breastfeeding with maternal serum PFOA, 
PFOS, PFNA, and PFHxS concentrations, 
and for a subset of the population, for whom 
we also have their infants’ measurements, to 
investigate the association of breastfeeding 
with infant PFAA serum concentrations.
Methods
Study population. The details of the C8 
Health Project study population, enrollment 
criteria, and consent procedures are described 
in a previous publication (Frisbee et al. 
2009). All participants gave written informed 
consent before inclusion; parents or guard­
ians provided consent on behalf of infants. 
The London School of Hygiene & Tropical 
Medicine (LSHTM) Ethics Committee 
approved this study. The C8 Health 
Project, conducted in 2005–2006, collected 
data from 35,788 females (of 69,030 par­
ticipants), including pregnancy information 
and measurements of 10 PFAAs in serum 
from 23,815 women (67%). Methods used 
for measurement of serum PFAAs and qual­
ity controls are described elsewhere (Frisbee 
et al. 2009). Briefly, the technique used 
solid­phase extraction followed by reverse­
phase high­ performance liquid chromato­
graphic separation and detection by tandem 
mass spectrometry. Estimates of precision 
for PFOA were within ± 10% for multiple 
replicates over the range of 0.5–40 ng/mL. 
Relative precision estimates for PFOS, PFNA, 
and PFHxS were similar to those for PFOA. 
The limit of detection (LOD) was 0.5 ng/mL 
for each PFAA, and observations below the 
LOD were assigned a value of 0.25 ng/mL.
The present study population comprises a 
subset of women who participated in the C8 
Health Project; consented for further study; 
were either pregnant or, if not, had a singleton 
born child < 3.5 years of age at the time of 
blood collection in 2005–2006; were resident 
in West Virginia or Ohio; and had measured 
PFAA concentrations during the 2005–2006 
survey. If they had had more than one child 
in that age range, only the youngest child was 
considered. Among the women who were eli­
gible for the initial study (n = 1,543), 87% 
were successfully contacted by phone and 
invited for telephone interview in 2011, and 
among them 878 (65%) participated. Because 
the present study focused on the impact of 
lactation on PFAA concentrations, the subset 
included in the current analysis was restricted 
to the 633 women who were not pregnant 
at the time of blood collection. Among their 
633 children < 3.5 years of age, 49 were infant 
participants in the C8 Health Project who also 
had serum PFAA concentrations measured in 
2005– 2006. Therefore, the final study sample 
was 633 mothers and 49 infants.
Breastfeeding. In the questionnaire on 
breastfeeding, mothers were asked to recall 
whether the infant was breastfed or not. 
If the child was breastfed, the mother was 
asked how long the child was breastfed. 
From the information provided, we deter­
mined the duration of lactation and the 
time from the end of lactation to the date of 
blood sampling.
Modeled PFOA uptake. We categorized 
ongoing maternal exposure to PFOA as a 
consequence of production activities from 
the DuPont plant based on modeled PFOA 
annual total dose estimates derived using envi­
ronmental, exposure, and pharmacokinetic 
modeling in conjunction with self­reported 
residential histories and tap water consump­
tion rates, as described in detail elsewhere 
(Shin et al. 2011b). Briefly, information on 
plant operations and chemical releases was 
combined with information on environmental 
characteristics of the region through a series of 
linked environmental fate and transport mod­
els to estimate air and water PFOA concentra­
tions during 1951–2008 (Shin et al. 2011a), 
and estimates of individual air and water 
intake rates were used to derive annual retro­
spective dose estimates for each participant 
(Shin et al. 2011b). For the present study, we 
used each mother’s modeled PFOA exposures 
to estimate her average exposure from the date 
of her index infant’s birth to the 2005–2006 
survey. On the basis of the distribution among 
the 633 mothers (average, 316 μg/year), we 
categorized ongoing PFOA exposure as none 
(0 μg/year), low (1–50 μg/year), medium 
(51–1,000 μg/year), or high (> 1,000 μg/year).
Our sample size was too small to stratify 
infants’ data by exposure levels as was done 
for mothers’.
Statistical analysis. To estimate the 
impact of breastfeeding on maternal 
serum PFAA concentrations (n = 633), we 
performed linear regression analyses with 
measured serum PFAA concentrations [natu­
ral log (ln) transformed to normalize] as the 
outcome, and the duration of breastfeeding 
as the predictor. We also adjusted for other 
potential determinants of serum PFAAs, spe­
cifically parity prior to the index pregnancy 
(categorized as 0, 1, 2, or > 2) (Brantsater 
et al. 2013), maternal age at survey (cat­
egorized into 5­year intervals), and infant age 
at survey (categorized into 6­month inter­
vals). In addition, for PFOA, the models 
were adjusted by water district of residence 
(Steenland et al. 2009). Duration of breast­
feeding was modeled as a categorical variable 
(0, ≤ 6, 7–12, > 12 months) or as a con­
tinuous variable. For PFOA only, analyses 
were also stratified to investigate whether the 
association between lactation and serum con­
centrations is modified by ongoing maternal 
PFOA exposure.
We considered other potential confound­
ers in the models: educational category for the 
mother (school, college or higher), reported 
household income in three categories and 
body mass index (BMI; categorized from 
underweight to obese). If the results didn’t 
change appreciably, being < 10% change in 
regression coefficients in the continuous mod­
els, they were not included in the final models 
for which results are presented.
To estimate the impact of breastfeed­
ing on infant serum PFAA concentrations 
(n = 49), we used regression analyses of ln 
infant serum PFAAs as the outcome and the 
duration of breastfeeding as the predictor, 
adjusted for infant’s age and (for PFOA only) 
water district.
We used the statistical software package 
STATA for all statistical analyses (version 12; 
StataCorp, College Station, TX, USA).
Results
In this study population, 60% (n = 379) of 
the mothers reported breastfeeding. The aver­
age age of the mothers (n = 633) and infants 
(n = 49) at the time of the 2005–2006 sur­
vey was 28 (range, 15–47) and 2.5 (range, 
1.7–3.4) years, respectively. Table 1 shows 
the demographics of the study population. 
Women who breastfed were more likely 
to be older than women who did not and 
seemed to have higher income and more 
education, whereas there were no observed 
pronounced differences in BMI, parity, or 
water district between them. Table 2 shows 
the serum PFAA concentrations in the study 
population stratified by the breastfeed­
ing categories. The geometric mean (GM) 
maternal and infant concentrations for this 
study population (all subjects) were similar 
to concentrations measured in the overall C8 
Health Project study population among all 
mothers 15–47 years of age (n = 12,621) and 
Lactational exposure to PFAAs
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among all infants 1–4 years (n = 236) (22.24, 
14.78, 1.23, and 2.38 ng/mL respectively for 
PFOA, PFOS, PFNA, and PFHxS for moth­
ers, and 39.75, 13.97, 1.30, and 3.70 ng/mL 
for PFOA, PFOS, PFNA, and PFHxS for 
infants, respectively). GM maternal serum 
PFAA concentrations were lower in mothers 
who breastfed the index child than in moth­
ers who did not breastfeed the index child. 
Conversely, breastfed infants had higher GM 
serum PFAA (except for PFNA) than infants 
who were never breastfed. Unadjusted differ­
ences were modest except for serum PFOA 
concentrations in infants, which were more 
than twice as high in breastfed infants (GM = 
49 ng/mL; 95% CI: 31, 79 ng/mL) than 
bottle­fed infants (GM = 22 ng/mL; 95% CI: 
11, 42 ng/mL).
Among the 379 mothers who reported 
breastfeeding, the average duration was 
3.5 months (range, < 1–35 months). At 
the time of 2005–2006 survey, 74 mothers 
were still breastfeeding and 305 had stopped 
breastfeeding, and for the latter the aver­
age time from end of lactation to survey 
was 11.2 months. Figure 1 shows maternal 
(n = 633), and infant (n = 49) serum PFAA 
concentrations stratified by the duration 
of breastfeeding. Although some trends of 
decrease in maternal serum concentrations 
and increase in infant serum concentrations 
with longer period of breastfeeding are sug­
gested, as clearly observed for PFOS (mater­
nal) and PFOA (infants), these are unadjusted 
means that may be confounded by other 
 predictors such as age and water district.
Table 3 shows the age­adjusted associa­
tion between maternal serum PFAA concen­
trations and the duration of breastfeeding, 
either categorical or as a continuous variable. 
Breastfeeding was associated with a reduc­
tion in maternal serum concentrations of 
3% (95% CI: –5, –2%) for PFOA, and 3% 
(95% CI: –3, –2%) for PFOS, 2% (95% CI: 
–2, –1%) for PFNA, and 1% (95% CI: 
–2, 0%) for PFHxS per month of breastfeed­
ing (though not significant for PFHxS). Except 
for PFHxS, maternal serum concentrations 
decreased monotonically as the duration of 
breastfeeding increased, although the confi­
dence intervals overlap. When breastfeeding 
duration was modeled as a continuous vari­
able, estimated decreases in maternal serum 
concentrations associated with 12 months of 
breastfeeding were 34% (95% CI: –44, –23%) 
for PFOA, 26% (95% CI: –34, –17%) for 
PFOS, 17% (95% CI: –24, –8%) for PFNA, 
and 12% (95% CI: –25, 1%) for PFHxS. 
However, only 7% (n = 27) of the breastfeed­
ing mothers reported breastfeeding for more 
than 12 months. Sensitivity analysis control­
ling for household income, years of school, and 
BMI did not indicate confounding because 
these factors changed coefficients far less than 
10% and so they were not included in the 
final models.
Table 4 shows the percent change for 
maternal PFOA concentrations per month 
of breastfeeding stratified by degree of ongo­
ing maternal exposure to PFOA. For moth­
ers who were not exposed to PFOA above 
background levels after the index child’s 
birth, serum concentrations were 7% lower 
(95% CI: –11, –2%) with each month of 
breastfeeding. Among women with ongoing 
exposure, serum PFOA concentrations were 
also negatively associated with breastfeeding, 
but differences were less pronounced, and 
estimates were close to the null for women 
with medium or high levels of ongoing expo­
sure. When the no­ and low­exposure group 
and the medium­ and high­exposure groups 
were each combined, serum PFOA concen­
trations were 4% lower (95% CI: –6, –3%) 
and 2% lower (95% CI: –4, 0%) with each 
month of breastfeeding, respectively.
Age­adjusted results for infants are pre­
sented in Table 5. The observed estimates are 
unstable given the small number of obser­
vations. Nevertheless, for infants who were 
Table 1. Demographic variables for the mothers (n = 633) in this study (breastfeeding referring to the 
index child).
Demographic variable
Breastfed index child  
(n = 379)
Did not breastfeed 
(n = 254) p-Value
Maternal age (years) (mean ± SD) 30 ± 6 28 ± 6 0.000a
Average household income [n (%)]b 0.000
≤ $20,000 79 (23.2) 72 (32.4)
> 20,000 to ≤ 70,000 204 (59.8) 133 (59.9)
> $70,000 58 (17.0) 17 (7.7)
Missing 38 32
Years of school [n (%)] 0.000b
< 12 years 15 (4.0) 25 (9.9)
High school diploma or GED 93 (24.5) 103 (40.7)
College education 179 (47.2) 93 (36.8)
Bachelor’s degree or higher 92 (24.3) 32 (12.6)
Missing 0 1
BMI (kg/m2) [n (%)]c 0.211b
Underweight (16.5–18.4) 8 (2.1) 13 (5.2)
Normal (18.5–24.9) 16 (42.7) 95 (38.2)
Overweight (25–29.9) 98 (26.1) 63 (25.3)
Obese Class I (30–34.9) 65 (17.3) 40 (16.1)
Obese Class II (35–39.9) 30 (8.0) 23 (9.2)
Obese Class III (≥ 40) 14 (3.7) 15 (6.0)
Missing 4 5
Parity [n (%)] before most recent pregnancy 0.597b
Nulliparous 120 (31.7) 87 (34.3)
1 131 (34.6) 91 (35.8)
2 79 (20.8) 42 (16.5)
> 2 49 (12.9) 34 (13.4)
Water district [n (%)] 0.218b
Belpre, OH 25 (6.6) 18 (7.1)
Tuppers Plain, OH 70 (18.5) 38 (15.0)
Little Hocking, OH 60 (15.8) 36 (14.2)
Lubeck, WV 38 (10.0) 18 (7.1)
Mason, WV 45 (11.9) 45 (17.7)
Pomeroy, OH 8 (2.1) 10 (3.9)
Othersd 133 (35.1) 89 (35.0)
at-test. bChi-square test. cBMI categories according to the World Health Organization (2000). dNot on public water supply 
from six water districts at time of providing serum sample; most of whom have lived in one of the six districts previously.
Table 2. Geometric means (95% CIs) of maternal and infant PFAA concentrations (ng/mL) stratified by reported breastfeeding category.
Breastfeeding 
category
Maternal serum PFAAs Infant serum PFAAs
n PFOA PFOS PFNA PFHxS n PFOA PFOS PFNA PFHxS
All 633 18.69 
(17.13, 20.28)
12.33 
(11.77, 12.92)
1.03 
(0.99, 1.07)
1.86 
(1.75, 1.97)
49 36.14 
(24.87, 52.52)
13.21 
(11.17, 15.61)
1.32 
(1.18, 1.48)
3.79 
(2.85, 5.04)
Breastfed 379 18.32 
(16.36, 20.50)
11.63 
(10.98, 12.31)
0.99 
(0.94, 1.04)
1.83 
(1.70, 1.97)
31 48.55 
(31.17, 75.61)
13.54 
(10.79, 17.00)
1.28 
(1.11, 1.48)
3.95 
(2.68, 5.83)
Child not breastfed 254 19.26 
(16.80, 22.08)
13.48 
(12.45, 14.58)
1.09 
(1.03, 1.15)
1.90 
(1.73, 2.08)
18 21.74 
(11.21, 42.17)
12.65 
(9.74, 16.43)
1.39 
(1.14, 1.70)
3.53 
(2.27, 5.48)
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breastfed for ≥ 12 months (n = 8), serum 
concentrations were significantly higher com­
pared with infants who were not breastfed 
for PFOA (141% higher; 95% CI: 4, 460%) 
and PFOS (71% higher; 95% CI: 9, 167%). 
Regression analysis of the infant PFAA con­
centrations on duration of breastfeeding mod­
eled as a continuous variable predicted 6% 
(95% CI: 1, 10%) and 4% (95% CI: 1, 7%) 
increase in PFOA and PFOS infant serum 
concentrations, respectively, with each month 
of breastfeeding. Weaker relationships were 
suggested for PFHxS and PFNA, with statisti­
cally nonsignificant associations. From the 
continuous regression, estimated increases 
in infant serum concentrations associated 
with 12 months of breastfeeding were 96% 
(95% CI: 16, 231%) for PFOA and 64% 
(95% CI: 21, 122%) for PFOS.
Discussion
Breastfeeding is the preferred nutrition for 
the infant, but the presence of environmental 
chemicals in breast milk has gained increased 
attention in recent years. Understanding 
the elimination rates of chemicals from the 
mother during breastfeeding is critical for 
assessing exposure in mothers and infants 
(LaKind et al. 2001). Though the concen­
trations of PFAAs in breast milk have been 
widely measured in different populations 
(Fromme et al. 2010; Kärrman et al. 2007; 
So et al. 2006; Tao et al. 2008; Voelkel et al. 
2008; von Ehrenstein et al. 2009), to the best 
of our knowledge very few data are avail­
able on the depuration rate of PFAAs due to 
lactation. We estimated that each month of 
breastfeeding was associated with maternal 
serum concentrations that were 3% lower 
for both PFOA and PFOS. Thomsen et al. 
(2010) estimated depuration rates of PFOA 
and PFOS due to breastfeeding by measuring 
PFOS and PFOA in milk samples collected 
from nine healthy primiparous mothers every 
month after birth up to 12 months, and esti­
mated annual reductions of 94% for PFOA 
and 37% for PFOS. The large apparent differ­
ence in the excretion rate for PFOA between 
Figure 1. Unadjusted geometric mean (GM) maternal (A) and infant (B) PFAA serum concentrations (ng/mL) and 95% CIs stratified by duration of breastfeeding. 
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Table 3. Association between maternal PFAA serum concentrations and duration of breastfeeding.
Breastfeeding duration n
PFOA PFOS PFNA PFHxS
Percent change 
(95% CI) p-Value
Percent change 
(95% CI) p-Value
Percent change 
(95% CI) p-Value
Percent change 
(95% CI) p-Value
Not breastfed 254 Reference Reference Reference Reference
≤ 6 months 251 –5 (–18, 8) 0.448 –9 (–18, 1) 0.078 –8 (–16, 0) 0.044 2 (–10, 16) 0.703
7–12 months 101 –29 (–41, –13) 0.001 –24 (–34, –13) 0.000 –18 (–27, –8) 0.001 –13 (–27, 4) 0.125
> 12 months 27 –41 (–57, –17) 0.002 –39 (–52, –23) 0.000 –24 (–37, –7) 0.007 –15 (–37, 15) 0.298
Continuous (per month) 633 –3 (–5, –2) 0.000 –3 (–3, –2) 0.000 –2 (–2, –1) 0.000 –1 (–2, 0) 0.08
Estimates were based on models of maternal lnPFAA concentrations adjusted for parity (0, 1, 2, > 2), maternal age (categorical in 5-year intervals), and infant´s age (categorical in 
6-month intervals). PFOA models were also adjusted for water district.
Table 4. Association between maternal PFOA serum concentrations and duration of breastfeeding (per month), stratified by level of ongoing maternal PFOA 
uptake.a
None (background exposure only) Low Medium High
n
Percent changeb 
(95% CI) p-Value n
Percent changeb 
(95% CI) p-Value n
Percent changeb 
(95% CI) p-Value n
Percent changeb 
(95% CI) p-Value
107 –7 (–11, –2) 0.006 299 –4 (–6, –3) 0.000 136 –2 (–5, 1) 0.258 91 –3 (–7, 1) 0.134
aEstimated as the average modeled exposure from the date of the index infant’s birth to the date of the 2005–2006 survey. bEstimates were based on models of maternal lnPFAA con-
centrations with duration of breastfeeding (per month) as a continuous variable, adjusted for parity (0, 1, 2, > 2), maternal age (categorical in 5-year intervals), infant´s age (categorical 
in 6-month intervals), and water district.
Table 5. Associations between infant serum PFAA concentrations and duration of breastfeeding.
Breastfeeding duration n
PFOA PFOS PFNA PFHxS
Percent change 
(95% CI) p-Value
Percent change 
(95% CI) p-Value
Percent change 
(95% CI) p-Value
Percent change 
(95% CI) p-Value
Not breastfed 18 Ref Ref Ref Ref
≤ 6 months 14 13 (–46, 139) 0.728 –31 (–53, 1) 0.058 –24 (–43, 0) 0.052 –20 (–62, 70) 0.562
7–12 months 9 82 (–23, 334) 0.168 40 (–9, 115) 0.119 2 (–26, 41) 0.875 45 (–38, 240) 0.373
> 12 months 8 141 (4, 460) 0.041 71 (9, 167) 0.021 17 (–17, 63) 0.356 46 (–40, 255) 0.392
Continuous (per month) 49 6 (1, 10) 0.014 4 (1, 7) 0.002 1 (–1, 3) 0.157 2 (–3, 7) 0.289
Estimates were based on models of infant lnPFAA concentrations adjusted for infant´s age (categorical in 6-month intervals). PFOA models were also adjusted for water district.
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the Thomsen et al. study and the present 
study (94% vs. 34%) may be explained by 
relatively high PFOA exposures in our study 
population compared with the Norwegian 
mothers (Thomsen et al. 2010). Our data 
for mothers living in nonexposed areas are 
more comparable to the Thomsen et al. study; 
we estimated a 7% decrease in serum PFOA 
per month of breastfeeding, equivalent to a 
60% decrease in PFOA concentrations after 
12 months of breastfeeding. Recently, a 
2–3% reduction in serum PFAA concentra­
tions per month of breastfeeding (with PFOA 
having the highest estimated decline of 2.4%) 
was reported in a study of 487 Norwegian 
mothers enrolled in the MoBa (Mother and 
Child Cohort Study) cohort (Brantsater et al. 
2013) based on measured concentrations dur­
ing gestation and the total number of months 
of breastfeeding reported for all previous 
children. The estimated loss from lactation 
is in addition to loss from normal metabo­
lism and net excretion, which has been esti­
mated to be approximately 22–13% per year 
in adults following cessation of exposure, 
given a half­life of 2.3–3.8 years (Bartell et al. 
2010; Olsen et al. 2007). Fei et al. (2010) 
reported that the duration of breastfeeding 
was negatively associated with serum PFOA 
and PFOS concentrations measured during 
pregnancy among 1,400 women enrolled in 
the Danish national birth cohort, but only 
among multiparous women. The authors sug­
gested that their findings could be explained 
if women who breastfed previous children for 
a relatively long time were also more likely to 
breastfeed the child included in the cohort 
study for a long period, and if their previous 
lactation also resulted in lower concentra­
tions of PFOA and PFOS during the index 
pregnancy. If so, their findings also would be 
consistent with those of the present study.
We can compare the observed depuration 
rate to that expected from average predicted 
excretion rates. Assuming average values of 
infant breast milk consumption of 700 mL/day 
(Thomsen et al. 2010) and partitioning of 
6.2% between maternal serum and breast milk 
[i.e., midway between the lowest (3.4%) and 
highest (9%) estimates previously reported for 
PFOA] (Haug et al. 2011; Kim et al. 2011; 
Liu et al. 2011), we estimate that the amount 
of PFOA excreted in breast milk by the mother 
(nanograms per day) is 43.4 times the maternal 
serum concentration (nanograms per milliliter) 
(43.4 is 6.2% of 700 mL). The volume of dis­
tribution per kilogram body weight for PFOA 
in females has been estimated as 198 mL/kg 
(Butenhoff et al. 2004), and the average body 
weight of the mothers in the study popula­
tion is 72.56 kg. The amount of PFOA in 
the mother’s body is thus estimated to be the 
product of volume of distribution, 14,366 mL, 
times the maternal serum concentration. 
Hence the proportional change in PFOA 
per day from mother’s body due to excretion 
via lactation is estimated to be 43.4/14,366, 
cumulating to an annual decrease of 33.1%, 
similar to what we have observed.
Another useful outcome of these results is 
to allow improvement in the exposure predic­
tion model for the in utero exposure of these 
mothers’ infants. For a mother who provided 
blood samples after weaning, we can take this 
lactation­related reduction of PFOA into 
account for back estimating their serum levels 
during the pregnancy.
To best of our knowledge, this is the first 
study investigating the association between 
breastfeeding and infant PFAA serum con­
centrations. We estimated significantly higher 
serum PFOA and PFOS concentrations in 
infants breastfed for > 12 months compared 
with non­breastfed infants, though estimates 
were imprecise because they were based on 
only eight infants in the long­duration group. 
These results are subject to small sample size, 
and we observed that the associations between 
duration of breastfeeding and infant serum 
PFOS, PFNA, and PFHxS concentrations 
were not monotonic, with the lowest serum 
concentrations estimated for infants breast­
fed for ≤ 6 months, and for PFNA the esti­
mates for the highest duration group were not 
clearly different from the null. Fitted as a con­
tinuous measure, each month of breastfeeding 
was associated with increase in 6% (95% CI: 
1, 10%) and 4% (95% CI: 1, 7%) infant 
serum PFOA and PFOS concentrations, 
respectively—equivalent to an estimated 
increase over 12 months of breastfeeding of 
96% (95% CI: 16, 231%) for PFOA and 
64% (95% CI: 21, 122%) for PFOS. The 
increase in PFNA and PFHxS infant serum 
concentrations with each month of breast­
feeding were not significant.
We have contrasted breastfeeding with 
formula feeding, and some of the water sup­
plies were still PFOA contaminated to an 
extent in the years just before 2005. Thus, the 
association with breastfeeding may be under­
estimated as a consequence of any exposure via 
tap water potentially used in mixing formula. 
Exposure to PFOA and PFOS in this popula­
tion has fallen, and we have found a steep 
downward trend in serum levels since 2005. 
Thus, the degree of mother­to­infant PFOA 
and PFOS transfer has been  consequently 
 falling in this community.
This study benefited from the measured 
maternal serum concentrations over a range of 
durations of breastfeeding, but is not longitu­
dinal, because repeated measured concentra­
tions were not collected during the course of 
breastfeeding to allow a direct estimate of actual 
change. It cannot be ruled out that other pro­
cesses occur during lactation which may affect 
excretion or blood volume and thus PFAA 
levels, or that women who choose to breastfeed 
also avoid food and drink sources with higher 
levels of contaminants. Nevertheless, our find­
ings are consistent with those of two previous 
studies (Brantsater et al. 2013; Thomsen et al. 
2010), which reported that breastfeeding was 
associated with lower serum PFAA concen­
trations in mothers. We found positive asso­
ciations of breastfeeding > 12 months (vs. no 
breastfeeding) and serum PFOA and PFOS 
in infants; however, estimates were based on 
small numbers of observations and must be 
interpreted with caution.
Conclusion
Our findings add to evidence suggesting that 
breastfeeding is an important PFAA excre­
tion route for lactating mothers and expo­
sure route for nursing infants. Each month 
of breastfeeding was associated with lower 
maternal serum PFAA concentrations. To our 
knowledge, we are the first to have estimated 
associations between breastfeeding and serum 
PFAA concentrations in infants, and although 
our findings were based on small numbers of 
observations, they provide preliminary evi­
dence that breastfeeding for > 6 months may 
increase serum PFOS and PFOA concentra­
tions in infants. Although breastfeeding can 
be an important PFAA excretion route for 
lactating mothers and exposure route for nurs­
ing infants, for most people, levels are very low 
and it is important to note that breast milk 
remains the optimal food for infants.
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